GoodRx (GDRX) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
16 Jun, 2026Opening remarks and agenda
Meeting commenced with introductions of board members, officers, and the independent auditor in attendance.
Agenda and rules of conduct were made available on the virtual meeting webpage, with voting eligibility and procedures explained.
Board and executive committee updates
Wendy Barnes, Ronald E. Bruehlman, and Gregory Mondre were nominated for election as Class C directors for a term expiring at the 2029 annual meeting.
Board members and executive officers were introduced, including the CEO, CFO, and Chief Accounting Officer.
Shareholder proposals
Three proposals were presented: election of Class C directors, ratification of KPMG LLP as auditor, and advisory approval of executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from GoodRx
- 2024 revenue rose 6% to $792.3M with 32.8% margin; 2025 guidance targets further profitable growth.GDRX
Q4 20249 Jul 2026 - Pharma Direct surged 82% in Q1 2026, offsetting declines in other segments and raising guidance.GDRX
Q1 20268 Jul 2026 - Q1 2025 revenue up 3%, net income positive, and margins strong amid strategic growth and guidance.GDRX
Q1 20258 Jul 2026 - Direct contracting and scalable solutions drive growth and margin expansion amid industry shifts.GDRX
UBS Global Healthcare Conference 20248 Jul 2026 - Direct contracting, ISP growth, and pharma solutions drive resilience amid retail volatility.GDRX
Citi's 2024 Global Healthcare Conference8 Jul 2026 - Q3 2024 revenue up 8%, net income $4.0M, margin gains, and Pharma Solutions growth offset headwinds.GDRX
Q3 20248 Jul 2026 - Board recommends approval of all proposals at the virtual 2026 Annual Meeting.GDRX
Proxy filing29 Apr 2026 - Definitive additional proxy materials filed to inform shareholders of voting matters.GDRX
Proxy filing29 Apr 2026 - Sharpened strategy and robust growth in integrated savings and pharma solutions drive margin gains.GDRX
Morgan Stanley 22nd Annual Global Healthcare Conference5 Apr 2026